Baluarte, Antonio .
HRN: 00-65-10 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
12/06/2022
12/12/2022
IV
4.5g IVT Now ANST Then 2.25g IVT Q8
4.5g IVT Now ANST Then 2.25g IVT Q8
CAP MR; T/C PTB Relapse; Bilateral Pleural Effusion More On Right
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: No Wrong Dose Wrong Dose
Overall appropriateness: No Wrong Dose